CS273750B1 - 2-(phenylthio) phenylalkylamines, their s-oxides and salts with dicarboxylic acids - Google Patents
2-(phenylthio) phenylalkylamines, their s-oxides and salts with dicarboxylic acids Download PDFInfo
- Publication number
- CS273750B1 CS273750B1 CS201489A CS201489A CS273750B1 CS 273750 B1 CS273750 B1 CS 273750B1 CS 201489 A CS201489 A CS 201489A CS 201489 A CS201489 A CS 201489A CS 273750 B1 CS273750 B1 CS 273750B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- phenylthio
- phenyl
- amine
- ether
- acid
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 6
- 150000001991 dicarboxylic acids Chemical class 0.000 title claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 18
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 10
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract description 6
- 235000019253 formic acid Nutrition 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- GYDSXMPGWUNZJC-UHFFFAOYSA-N 2-phenylsulfanylbenzaldehyde Chemical compound O=CC1=CC=CC=C1SC1=CC=CC=C1 GYDSXMPGWUNZJC-UHFFFAOYSA-N 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 230000011987 methylation Effects 0.000 abstract description 3
- 238000007069 methylation reaction Methods 0.000 abstract description 3
- 238000006386 neutralization reaction Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- SUGQEXQMLNVOKY-UHFFFAOYSA-N 1-(2-phenylsulfanylphenyl)propan-2-one Chemical compound CC(=O)CC1=CC=CC=C1SC1=CC=CC=C1 SUGQEXQMLNVOKY-UHFFFAOYSA-N 0.000 abstract description 2
- 238000006547 Leuckart Thiophenol synthesis reaction Methods 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000891 anti-reserpine Effects 0.000 abstract description 2
- 239000000935 antidepressant agent Substances 0.000 abstract description 2
- 229940005513 antidepressants Drugs 0.000 abstract description 2
- 150000003948 formamides Chemical class 0.000 abstract description 2
- 230000022244 formylation Effects 0.000 abstract description 2
- 238000006170 formylation reaction Methods 0.000 abstract description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract description 2
- 239000011976 maleic acid Substances 0.000 abstract description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 3
- 150000003141 primary amines Chemical class 0.000 abstract 3
- 150000003335 secondary amines Chemical class 0.000 abstract 2
- 150000003512 tertiary amines Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 235000006408 oxalic acid Nutrition 0.000 abstract 1
- 150000003568 thioethers Chemical class 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 150000001412 amines Chemical class 0.000 description 12
- 238000001816 cooling Methods 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 9
- -1 N-Methyl-1- (2- (phenylsulfinyl) phenyl) -2-propylamine Chemical compound 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- FWWOWPGPERBCNJ-UHFFFAOYSA-N 2-hydroxy-4-(2-hydroxyethoxy)-4-oxobutanoic acid Chemical compound OCCOC(=O)CC(O)C(O)=O FWWOWPGPERBCNJ-UHFFFAOYSA-N 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 4
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 4
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- YFCHMEKCUKTZHE-UHFFFAOYSA-N n,n-dimethyl-1-(2-phenylsulfanylphenyl)propan-2-amine Chemical compound CN(C)C(C)CC1=CC=CC=C1SC1=CC=CC=C1 YFCHMEKCUKTZHE-UHFFFAOYSA-N 0.000 description 4
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 4
- 229960003147 reserpine Drugs 0.000 description 4
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229960003914 desipramine Drugs 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000002631 hypothermal effect Effects 0.000 description 3
- RAHQYFXENSUGDT-UHFFFAOYSA-N n,n-dimethyl-2-(2-phenylsulfanylphenyl)ethanamine Chemical compound CN(C)CCC1=CC=CC=C1SC1=CC=CC=C1 RAHQYFXENSUGDT-UHFFFAOYSA-N 0.000 description 3
- HOPYVEWIFRKSQV-UHFFFAOYSA-N n-methyl-1-(2-phenylsulfanylphenyl)propan-2-amine Chemical compound CNC(C)CC1=CC=CC=C1SC1=CC=CC=C1 HOPYVEWIFRKSQV-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- UKJQLHNCSHSGGK-UHFFFAOYSA-N 1-[2-(benzenesulfinyl)phenyl]propan-2-amine Chemical compound CC(N)CC1=CC=CC=C1S(=O)C1=CC=CC=C1 UKJQLHNCSHSGGK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010015995 Eyelid ptosis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000001539 anorectic effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 210000003016 hypothalamus Anatomy 0.000 description 2
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 2
- 229960004801 imipramine Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-M oxalate(1-) Chemical compound OC(=O)C([O-])=O MUBZPKHOEPUJKR-UHFFFAOYSA-M 0.000 description 2
- 201000003004 ptosis Diseases 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- VAVHMEQFYYBAPR-ITWZMISCSA-N (e,3r,5s)-7-[4-(4-fluorophenyl)-1-phenyl-2-propan-2-ylpyrrol-3-yl]-3,5-dihydroxyhept-6-enoic acid Chemical compound CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(C=2C=CC(F)=CC=2)=CN1C1=CC=CC=C1 VAVHMEQFYYBAPR-ITWZMISCSA-N 0.000 description 1
- SXJIMCNPMBDKLZ-UHFFFAOYSA-N 1-(2-nitroethenyl)-2-phenylsulfanylbenzene Chemical compound [O-][N+](=O)C=CC1=CC=CC=C1SC1=CC=CC=C1 SXJIMCNPMBDKLZ-UHFFFAOYSA-N 0.000 description 1
- FADJIMDKDQYNCG-UHFFFAOYSA-N 1h-azet-2-one Chemical compound O=C1NC=C1 FADJIMDKDQYNCG-UHFFFAOYSA-N 0.000 description 1
- POEOFFRTAAOWOX-UHFFFAOYSA-N 2-(2-phenylsulfanylphenyl)acetonitrile Chemical compound N#CCC1=CC=CC=C1SC1=CC=CC=C1 POEOFFRTAAOWOX-UHFFFAOYSA-N 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- PIAOLBVUVDXHHL-UHFFFAOYSA-N 2-nitroethenylbenzene Chemical compound [O-][N+](=O)C=CC1=CC=CC=C1 PIAOLBVUVDXHHL-UHFFFAOYSA-N 0.000 description 1
- HIHOEGPXVVKJPP-JTQLQIEISA-N 5-fluoro-2-[[(1s)-1-(5-fluoropyridin-2-yl)ethyl]amino]-6-[(5-methyl-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile Chemical compound N([C@@H](C)C=1N=CC(F)=CC=1)C(C(=CC=1F)C#N)=NC=1NC=1C=C(C)NN=1 HIHOEGPXVVKJPP-JTQLQIEISA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 229920004449 Halon® Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical class NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- HZZOEADXZLYIHG-UHFFFAOYSA-N magnesiomagnesium Chemical compound [Mg][Mg] HZZOEADXZLYIHG-UHFFFAOYSA-N 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 description 1
- RPMTZTCTVQCHMU-UHFFFAOYSA-N n-methyl-2-(2-phenylsulfanylphenyl)ethanamine Chemical compound CNCCC1=CC=CC=C1SC1=CC=CC=C1 RPMTZTCTVQCHMU-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- GEVPUGOOGXGPIO-UHFFFAOYSA-N oxalic acid;dihydrate Chemical compound O.O.OC(=O)C(O)=O GEVPUGOOGXGPIO-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000018770 reduced food intake Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Vynález bo týká 2-(fonylthio)fenylolkylaminú a jejich S-oxidň obočného vzorce I,The invention relates to 2- (phonylthio) phenyl-amines and their S-oxides of the general formula I,
TO. / ve kterém R, P/ a Rc jsou stejné nebo různé a značí atom vodíku nebo methyl a n značí 0 nebo 1» jakož 1 jejich solí s dikarboxylovými kyselinami.IT. / Wherein R, P / C, and R are identical or different and denote hydrogen or methyl, n represents 0 or 1 »1 and of their salts with dicarboxylic acids.
Látky vzorce I ve formě solí vykazují psychotropní aktivitu s převážnými rysy charakteru antidepreslv. Vykazují zčásti mírné účinky centrálně tlumivé, zčásti mírná excitační, jsou v testech na zvířatech účinné antlreserpinově a mají mírnou afinitu k vazným místům (receptorům) pro imipramin a desipramin v hypothalamu krysího mozku. Lze předpokládat jejich praktickou použitelnost v terapii duševních depresivních stavů.The compounds of formula I in the form of salts show psychotropic activity with predominantly antidepressant character. They show partly mild centrally suppressing effects, partly mild excitatory effects, are antlreserpine-active in animal tests and have a slight affinity for the imipramine and desipramine binding sites (receptors) in the rat brain hypothalamus. Their practical applicability in the treatment of mental depressive states can be assumed.
Testovány byly následující látky:The following substances were tested:
2-(2-(Penylthio)fenyl)ethylamln (Ia),2- (2- (Penylthio) phenyl) ethylamine (Ia),
N-Methyl-2-(2-(fenylthio)fenyl)ethylamin (Ib), N,N-dimethyl-2-(2-(fenylthio)fenyl)ethylamin (Ic), l-(2-(Penylthio)fenyl)-2-propylamin (Id),N-Methyl-2- (2- (phenylthio) phenyl) ethylamine (Ib), N, N-dimethyl-2- (2- (phenylthio) phenyl) ethylamine (Ic), 1- (2- (Penylthio) phenyl) -2-propylamine (1d),
N-Metbyl-l-(2-(fenylthio)fenyl)~2-propylamin (Ie), N,N-Dimethyl-l-(2-(fenylthio)fenyl)-2-propylamin (If), l-(2~(Penylsulfinyl)fenyl)-2-propylamin (Ig), N-Methyl-l-(2-(fenylsulfinyl)fenyl)-2-propylamin (Ih) a N»N-Dimethy1-1-(2-(fenylsulflnyl)fenyl)-2-propylamin (li).N-Methyl-1- (2- (phenylthio) phenyl) -2-propylamine (Ie), N, N-Dimethyl-1- (2- (phenylthio) phenyl) -2-propylamine (If), 1- (2 - (Penylsulfinyl) phenyl) -2-propylamine (Ig), N-Methyl-1- (2- (phenylsulfinyl) phenyl) -2-propylamine (Ih) and N, N-Dimethyl-1- (2- (phenylsulfinyl)) phenyl) -2-propylamine (1i).
Všechny látky byly aplikovány ve formě hydrogenmaleinátů (s výjimkou látek Ib a le, které byly použity ve formě hydrogenoxalatů) a byly podávány orálně, pokud není uvedeno jinak.All agents were administered in the form of hydrogen maleate (except Ib and le, which were used in the form of hydrogenoxalates) and were administered orally unless otherwise indicated.
Akutní toxicita na myších, LD^0 v mg/kg: Ia, 525; Ib, 40 i,v.; Ic, 288; Id, 158; le, 216; If, l?3t Ig, 352; Ih, 377l li, 170.Acute toxicity in mice, LD ^ 0 mg / kg: Ia, 525; Ib, 40 i, v .; Ic, 288; Id, 158; le, 216; If, 1,3t Ig, 352; Ih, 377l li, 170.
Dále význačnější účinky několika vybraných látek:Further significant effects of several selected substances:
Ia, v dávce 50 mg/kg signifikantně antagonizuje reserpinovou ptosu u myší; v dávkáchIa, at a dose of 50 mg / kg, significantly antagonizes reserpine ptosis in mice; in batches
100 až 200 mg/kg chrání myší přod hypothermiokým účinkem reserpinu. Má mírnou afinitu k vazným místům pro imipramin a desipramin v krysím hypothalamu; Inhibice100 to 200 mg / kg protects mice from the hypothermic effect of reserpine. It has a slight affinity for the binding sites for imipramine and desipramine in rat hypothalamus; Inhibition
3 vazby 4 nfí /JH/ lmipraminu a 4 nM /JH/ desipraminu; ΙΟ^θ 873, resp. 711 nfí,3 linkages NFI 4 / J H / lmipraminu and 4 nM / J H / desipramine; 8 ^ θ 873, respectively. 711 nfí,
Ic, v i,p, dávce 8 mg/kg vykazuje mírný hypothermický účinek u myší.Ic, at i, p, at a dose of 8 mg / kg shows a slight hypothermic effect in mice.
Ie, v dávce 25 mg/kg má výrazný antireserpinový účinek v testu ptosy u myší; v dávce mg/kg signifikantně antagonizuje tvorbu žaludečních vředů u krys, vyvolanou reserpinem; v dávce 10 mg/kg výrazně antagonizuje reserpinovou hypothermii u myší; v orální dávce 100 mg/kg a v časovém intervalu 1-4 vykazuje anorektický účinek u krys.Ie, at a dose of 25 mg / kg, has a pronounced antireserpine effect in the ptosis test in mice; at a dose of mg / kg, it significantly antagonizes reserpine-induced gastric ulceration in rats; at 10 mg / kg significantly antagonizes reserpine hypothermia in mice; at an oral dose of 100 mg / kg and at a time interval of 1-4 showed anorectic effect in rats.
Ig, po podání dávky 100 mg/kg prokazuje signifikantní anorektický efekt (snižuje příjem potravy) u krys v intervalu 1 h po podání.Ig, following a 100 mg / kg dose, showed a significant anorectic effect (reduced food intake) in rats at 1 hour post-dose.
-v· -in·
......
CS 273750 Bl li, v dávce 10 mg/kg signifikantně snižuje lokomotorickou aktivitu myší v intervalu h po podání (centrálně tlumivý efekt).CS 273750 B1, at a dose of 10 mg / kg significantly reduced the locomotor activity of the mice at an interval h after administration (central suppressive effect).
Látky vzorce I podle vynálezu jsou přístupné různými metodami podle etupně methylace na uhlíku alifatické řetězce a na atomu dusíku. Látky 2-fenylethylaminové řady jsou přístupné z 2-(fenylthio)benzald^hydu (M, Hoři et al,, Tetrahedron Lett. 1978,The compounds of formula I according to the invention are accessible by various methods according to the step of methylation at the carbon of the aliphatic chain and at the nitrogen atom. The compounds of the 2-phenylethylamine series are accessible from 2- (phenylthio) benzaldehyde (M, Hori et al., Tetrahedron Lett. 1978,
255? NSR zveřejňovací spis ě. 2 165 26ρ), který se převede na l-nitro-2-(2-(fenylthio)« fenyDethen. Jeho redukcí, např. hydridem lithnohlinitým, se získá látka la. Její formylací a redukcí resultuje látka lb. Přímou methylaoí látky la kyselinou mravenčí a formaldehydem se získá látka lo. Příprava látek l-fenyl-2«propylaminové řady vychází z nového (2-(fenylthio)fenyl)aoetonu (jeho příprava je popsána v příkladu). Z této látky Leuckartovou reakcí se získá N-(l-(2-(fenylthio)fenyl)-2«propyl)formamid, který alkalickou hydrolýzou poskytuje látku'íld, a redukcí hydridovými činidly látku la. Látka lf se získá z látky Id methylaoí formaldehydem a kyselinou mravenčí. Sulfoxidy se připraví oxidací příslušných sulfidů peroxidem vodíku v kyselině octové. Všechny produkty jsou basické povahy a neutralizací kyselinami poskytují soli, z nichž hydrogenmaleinaty (zčásti též hydrogenoxalaty) dobře krystalizují. Všechny látky ve vynálezu popsané jsou nové. Jejich Identita by.ía zajištěna obvyklými analytickými a spektrálními metodami. Pomocí uvedených příkladů jsou znázorněny možnosti přípravy látek podle vynálezu.255? NSR publication file. 2165 26), which is converted to 1-nitro-2- (2- (phenylthio) phenylene) by its reduction, e.g. lithium aluminum hydride, to give 1a. Its formylation and reduction results in 1b. The preparation of 1-phenyl-2'-propylamine series starting from the new (2- (phenylthio) phenyl) azetone (the preparation of which is described in the example) is obtained from this compound by the Leuckart reaction to give N- (1). - (2- (phenylthio) phenyl) -2-propyl) formamide which provides alkaline hydrolysis with compound ld and reduction with hydride reagents compound 1a. Compound 1f is obtained from compound 1d with methyl formaldehyde and formic acid. Hydrogen peroxide in acetic acid All products are basic in nature and provide acid neutralization to provide salts from which hydrogen maleate (partially hydrogenated oxalates) crystallize well. Their identity was assured by the usual analytical and spectral methods. The following examples illustrate the preparation possibilities of the compounds according to the invention.
Příklad 1Example 1
2-(2-(Penylthio)fenyl)ethylamin (la)2- (2- (Penylthio) phenyl) ethylamine (1a)
K míchanému roztoku 18,7 g thiofenolu ve 42 ml hexamethyltriamidu kyseliny fosforečné se přidá roztok 6,8 g hydroxidu Bodného v 13 ml vody a po 10 minutách ještěTo a stirred solution of 18.7 g of thiophenol in 42 ml of hexamethylphosphoric triamide was added a solution of 6.8 g of Bodium hydroxide in 13 ml of water and after 10 minutes still
22,5 g 2-chlorbenzaldehydu. Směe se zahřívá 3,5 h pod zpětným chladičem na 100 °C v dusíkové atmoBféře. Po částečném ochlazení se vlije do 300 ml ledově ohledné vody a produkt se izoluje extrakcí benzenem. Zpracováním odparku a destilací zbytku ve vakuu se získá 29,4 g (85 %) 2-(fenylthio)benzaldehydu, t. v, 130 až 135 °C/67 Pa. Látka poskytuje eemikarbazon, který krystalizuje z ethanolu a taje při 212 až 215 °C.22.5 g of 2-chlorobenzaldehyde. The mixture was refluxed at 100 ° C for 3.5 h in a nitrogen atmosphere. After partial cooling, it is poured into 300 ml of ice-water and the product is isolated by extraction with benzene. Workup of the residue and distillation of the residue in vacuo afforded 29.4 g (85%) of 2- (phenylthio) benzaldehyde, m.p. The compound gives eemicarbazone, which crystallizes from ethanol and melts at 212-215 ° C.
Směs 30,0 g předešlého aldehydu,-.12,8 g nitromethanu, 120 ml kyseliny octové a 12 g octanu amonného se míchá a vaří 4 h pod zpětným chladičem. Po ochlazení se nalije do vody a produkt se extrahuje etherem. Extrakt ee promyje 5% roztokem uhličitanu sodného a vodou, vysuší se a odpaří. Zbytek je 34,7 g (96 %) téměř homogenního olejovitého l-nitro-2-(2-(fenylthio)fenyl)ethenu. Vzorek pro analýzu lze ještě přečistit destilací? t. v. 180 °C/0,2 kPa.A mixture of 30.0 g of the previous aldehyde, 12.8 g of nitromethane, 120 ml of acetic acid and 12 g of ammonium acetate is stirred and refluxed for 4 hours. After cooling, it is poured into water and the product is extracted with ether. The extract was washed with 5% sodium carbonate solution and water, dried and evaporated. The residue was 34.7 g (96%) of an almost homogeneous oily 1-nitro-2- (2- (phenylthio) phenyl) ethene. Can the sample be analyzed by distillation? mp 180 ° C / 0.2 kPa.
Roztok 25,0 g předešlého nitrostyrenu ve 150 ml etheru se za míchání přikape během 3 h k míchanému roztoku 19 g hydridu lithnohlinitého v 300 ml etheru. Směe se ponechá v klidu 2 dny při teplotě místnosti, potom se rozloží pomalým přidáním ethanolu a vody, pevná látka se odfiltruje, filtrát se rozdělí a organická vrstva se odpařitA solution of 25.0 g of the above nitrostyrene in 150 ml of ether was added dropwise over 3 hours to a stirred solution of 19 g of lithium aluminum hydride in 300 ml of ether. The mixture is allowed to stand at room temperature for 2 days, then quenched by the slow addition of ethanol and water, the solid is filtered off, the filtrate is separated and the organic layer is evaporated.
18,8 g (84 %) surového aminu la. Rozpustí se v etheru, roztok se zneutralizuje roztokem 9,0 g kyseliny maleinovó v ethanolu a směs se zředí etherem. Vykrystalizuje 13,2 g hydrogenmaleinatu, t. t, 154 až 155 °C (ethanolether).18.8 g (84%) of crude amine 1a. Dissolve in ether, neutralize with 9.0 g maleic acid in ethanol and dilute with ether. Crystallize 13.2 g of hydrogen maleate, m.p. 154-155 ° C (ethanol ether).
Příklad 2Example 2
N-Methyl-2-(2-fenylthio)fenyl)ethylamin (lb)N-Methyl-2- (2-phenylthio) phenyl) ethylamine (1b)
Směs 16,4 g aminu la a 45 ml mravenčenu ethylnatého se zahřívá 6 h v autoklávu naA mixture of 16.4 g of amine 1a and 45 ml of ethyl formate is heated in an autoclave for 6 hours
125 až 130 °C. Reakční směa se rozpustí v etheru, roztok se promyje zředěnou .kyselinou chlorovodíkovou a 5% roztokem hydrogenuhličitanu sodného, vysuší se a odpaří. Získá seMp 125-130 ° C. The reaction mixture was dissolved in ether, washed with dilute hydrochloric acid and 5% sodium bicarbonate solution, dried and evaporated. It is obtained
16,2 (88 %) příslušného formamidového derivátu, který se v tomto stavu použije pro další reakce. Rozpustí se v 80 ml benzenu a roztok se přikape k míchanému roztoku 6,0 g16.2 (88%) of the corresponding formamide derivative used in this state for the next reactions. It was dissolved in 80 ml of benzene and the solution was added dropwise to a stirred solution of 6.0 g
Ί&Ί &
ΆΆ
f.’F.'
A. ,A.,
CS 273750 Bl hydridu lithnohlinitého v 70 ml etheru. Směe 09 míchá a vaří pod zpětným chladičem 5 h.CS 273750 B1 lithium aluminum hydride in 70 ml ether. The mixture 09 is stirred and refluxed for 5 h.
Po ochlazení ae rozloží pomalým přidáním othanolu a vody, zfiltruje ao, organická fáze filtrátu no vyeuěí a odpaří. Zbytek (14,5 g, 95 %) představuje téměř homogenní amin lb.After cooling and decomposing by the slow addition of ethanol and water, the organic phase of the filtrate is filtered and evaporated. The residue (14.5 g, 95%) is an almost homogeneous amine 1b.
Neutralizuje se dihydrátem kyseliny oxalové v ethanolu a roztok se zředí etherem. Vykrystalizuje 6,4 g hydrogenoxalatu, t. t. 190 °C (ethanol-ether).Neutralize with oxalic acid dihydrate in ethanol and dilute the solution with ether. 6.4 g of hydrogen oxalate crystallized, m.p. 190 DEG C. (ethanol-ether).
Příklad 3Example 3
N,N-Dimethyl-2-(2-(fenylthio)fsnyl)ethylamin (IC)N, N-Dimethyl-2- (2- (phenylthio) phenyl) ethylamine (IC)
Směs 13,0 g aminu Ia, 12 ml 00% kyseliny mravenčí, 21,5 ml 20% formaldehydu o 10 ml vody se míchá a vaří 11 h pod zpětným chladičem. Po ochlazení o,o vlije do zředěného roztoku hydroxidu sodného, extrahuje se etherem, extrakt se promyje vodou, vysuší a odpaří. Získá se 12,7 g (Θ7 %)-téměř homogenního aminu lc, který se převede no maleinat, t. t, 100 až 102 °C (ethanol-ether).A mixture of 13.0 g of amine Ia, 12 ml of 00% formic acid, 21.5 ml of 20% formaldehyde and 10 ml of water is stirred and refluxed for 11 hours. After cooling, it is poured into dilute sodium hydroxide solution, extracted with ether, the extract is washed with water, dried and evaporated. 12.7 g (Θ7%) of an almost homogeneous amine 1c are obtained, which is converted to maleeate, m.p. 100 DEG-102 DEG C. (ethanol-ether).
Příklad 4 l-(2-(Penylthio)fenyl)-2-propylamin (Id)Example 4 1- (2- (Penylthio) phenyl) -2-propylamine (1d)
K míchané suspenzi 3,5 g 00% hydridu sodného v 50 ml toluenu so při 70 °C přikape 13,3 ml othanolu. K vzniklé suspenzi othoxidu sodného so přidá nměs 20 g (2-(fenylthio)fenyl)acetonitrilu (J. O. Jílek et al., Monatsh, Chem, 96, 182 (1965)) a 13,3 ml ethylacetátu. Směs se vaří 2 h pod zpětným chladičem. Po ochlazení eo rozloží přídavkem 110 ml vody, toluenový roztok se promyje vodou, spojené vodné roztoky se ochladí na 0 °C 0 okyselí ee kyselinou chlorovodíkovou nn pH 2 až 3, Vyloučený olej se extrahuje toluenem, extrakt se vysuší a zpracuje destilací: 13,5 g (57 %) 3-oxo-2-(2-(fonylthio)fenyl)butyronitrilu, t, v, 157 až 158 °C/70 Pa.To a stirred suspension of 3.5 g of 00% sodium hydride in 50 ml of toluene at 70 ° C was added dropwise 13.3 ml of ethanol. A mixture of 20 g of (2- (phenylthio) phenyl) acetonitrile (J.O. Jílek et al., Monatsh, Chem. 96, 182 (1965)) and 13.3 ml of ethyl acetate are added to the resulting sodium othoxide suspension. The mixture was refluxed for 2 h. After cooling, the reaction is quenched by the addition of 110 ml of water, the toluene solution is washed with water, the combined aqueous solutions are cooled to 0 ° C and acidified with hydrochloric acid at pH 2 to 3. The oil which has precipitated is extracted with toluene. 5 g (57%) of 3-oxo-2- (2- (phonylthio) phenyl) butyronitrile, mp 157-158 ° C / 70 Pa.
Směs 12,0 g předešlého nitrilu a 10,4 g kyseliny fosforečné se zahřívá pod zpětným chladičem 8 h v lázni o teplotě 200 °C, Po ochlazení se smšs zředí 50 ml vody a produkt Be extrahuje toluenem. Zpracováním extraktu a destilací se získá 7,1 g (65 %) (2-(fenylthio)fenyl)acetonu, t, v, 128 až 130 °C/90 Pa, který krystalizuje z ethanolu a taje při 50 až 51,5 °C,A mixture of 12.0 g of the previous nitrile and 10.4 g of phosphoric acid was refluxed for 8 hours in a 200 ° C bath. After cooling, the mixture was diluted with 50 ml of water and the product Be extracted with toluene. Treatment of the extract and distillation gave 7.1 g (65%) of (2- (phenylthio) phenyl) acetone, mp 128-130 ° C / 90 Pa, which crystallized from ethanol and melted at 50-51.5 ° C. C,
Směs 6,0 g předešlého acetonového derivátu, 15 g formamidu a 3,0 g 98% kyseliny mravenčí se vaří 12 h pod zpětným chladičem v lázni o teplotě 190 až 200 °C, Po částečném ochlazení se směs vlije do vody a produkt se extrahuje etherem. Zpracováním extraktu se získá 6,6 g (téměř teoretické množství) olejovitého N-(l-(2-(fenylthio)fenyl)-2~propyl)formamidu, který se dále použije v tomto stavu. Pro charakterizaci lze vzorek (5,0 g) vyčistit chromatografií na 70 g silikagélu. Chloroformem se eluuje 4,2 g homogenního produktu, který krystalizuje z petroletheru, t, t, 66 až 68 °C (benzen-hexan).A mixture of 6.0 g of the preceding acetone derivative, 15 g of formamide and 3.0 g of 98% formic acid is heated under reflux in a bath at 190 to 200 ° C for 12 h. After partial cooling, the mixture is poured into water and the product is extracted ether. Working up the extract yielded 6.6 g (almost theoretical amount) of oily N- (1- (2- (phenylthio) phenyl) -2-propyl) formamide, which was used as such. For characterization, a sample (5.0 g) can be purified by chromatography on 70 g silica gel. Chloroform eluted with 4.2 g of a homogeneous product which crystallized from petroleum ether, mp 66-68 ° C (benzene-hexane).
Surový předešlý amid (6,6 g) se přidá k roztoku 6,6 g hydroxidu draselného v 8,0 ml ethanolu a směs se vaří 4,5 h pod zpětným chladičom (lázeň 120 až 130 °C). Γο ochlazení se zředí 129 ml vody, extrahuje se etherem a extrakt se zpracuje vysušením a odpařením. Zbytek se rozpustí v' přebytečné 5% kyselině chlorovodíkové, kyselý roztok se promyje etherem, zalkalizuje se vodným amoniakem a base se znovu extrahuje etherem. Zpracováním extraktu se získá 4,2 g (70 %) olejovitého aminu Id, který se převede neutralizačními roakcomi na tyto neliš hydrogonmaloinot, t, t, 1-10 nž 141 °C (ethanol): hydroohlorld, t, t, 168 až 171 °C (ethanol-ether).The crude previous amide (6.6 g) was added to a solution of 6.6 g potassium hydroxide in 8.0 ml ethanol and the mixture was refluxed for 4.5 h (bath 120-130 ° C). Cooling is diluted with 129 ml of water, extracted with ether and the extract is worked up by drying and evaporation. The residue was dissolved in excess 5% hydrochloric acid, the acidic solution was washed with ether, basified with aqueous ammonia and the base extracted again with ether. Treatment of the extract yielded 4.2 g (70%) of the oily amine Id, which was converted by neutralization to the following non-hydrogen halon, mp, 1-10 ° C to 141 ° C (ethanol): hydro-chloride, t, t, 168-171 ° C (ethanol-ether).
Příklad 5Example 5
N-Methyl-l-(2-(fenylthio)fenyl)-2-propylamin (le)N-Methyl-1- (2- (phenylthio) phenyl) -2-propylamine (1e)
Roztok 17,3 g olejovitóho N-(l-(2-(fenylthio)fanyl)-2-propyl)formamidu v 75 ml etheru se přikape k míchanému roztoku 7,2 g hydridu lithnohlinitého v 75 ml etheru a směs se vaří 6 h pod zpětným chladičem. Za chlazení se rozloží pomalým přidáním 7,2 mlA solution of 17.3 g of oily N- (1- (2- (phenylthio) phanyl) -2-propyl) formamide in 75 ml of ether was added dropwise to a stirred solution of 7.2 g of lithium aluminum hydride in 75 ml of ether and the mixture was boiled for 6 h. under reflux. It is decomposed under cooling by the slow addition of 7.2 ml
15% hydroxidu sodného1 a 30 ml vody. Míchá se 30 min, pevná látka se odfiltruje,.flítáCS 273750 Bl15% sodium hydroxide 1 and 30 ml water. Stir for 30 min, filter the solid, filter with CS 273750 B1
3’fíL on vyoučí nírnnom hořočnatým, zfiltrujo ae o aktivním uhlím o odpaří. Zbytek je 15,7 g (83 %) téměř homogenního olejovitého aminu Ie. Poakytuje krystalický hydrogenoxalnt tající při 137 až 139 °C (ethanol-ether).He teaches magnesium magnesium, filtered and vaporized on activated carbon. The residue is 15.7 g (83%) of an almost homogeneous oily amine Ie. It covers a crystalline hydrogen oxalate melting at 137-139 ° C (ethanol-ether).
Příklad 6Example 6
N,N-Dimethy1-1-(2-(fenylthio)fenyl)-2-propylamin (If)N, N-Dimethyl-1- (2- (phenylthio) phenyl) -2-propylamine (If)
Směn 11,0 g ninlnu Id, 0 ml vody, 11,0 ml 00% kyseliny mravenčí o 19 ml 2β% formaldehydu se míchá a vaří 12 h pod zpětným chladičem. Po ochlazení se nalije do 330 ml 5% roztoku hydroxidu sodného a produkt se extrahuje etherem. Extrakt ae promyje vodou, vysuší, zfiltruje s aktivním uhlím a odpaří. Získá bo 10,8 g (88 '%)'•prakticky homogenního olejovitého aminu If, který se převede na hydrogenmaleinat, ť-.-At, 84 až 86 °C (ethanol-ether).Shift 11.0 g of nin Id, 0 ml of water, 11.0 ml of 00% formic acid with 19 ml of 2β% formaldehyde are stirred and refluxed for 12 hours. After cooling, it is poured into 330 ml of 5% sodium hydroxide solution and the product is extracted with ether. The extract was washed with water, dried, filtered with charcoal and evaporated. 10.8 g (88%) of a practically homogeneous oily amine If are obtained, which is converted to hydrogen maleate, mp 84-86 ° C (ethanol-ether).
Příklad 7Example 7
1-(2-(Fenylsulfiny1)fenyl)-2-propylamin (Ig)1- (2- (Phenylsulfinyl) phenyl) -2-propylamine (Ig)
Roztok 1,2 g aminu Id v 12 ml kyseliny octové ae oxiduje pomocí 0,8 g peroxidu vodíku a směs so ponechá 24 h při teplotě místnosti. Potom ao zředí 150 ml vody, zolknlizuje oe 45 ml 20% hydroxidu aodnéhó a produkt ae izoluje extrakoí benzenem; 0,90 g (70 %) olejovitého Ig, Hydrogenmaleinat, t. t. 176 až 177 °C (ethanol).A solution of 1.2 g of amine Id in 12 ml of acetic acid is oxidized with 0.8 g of hydrogen peroxide and the mixture is left at room temperature for 24 h. It is then diluted with 150 ml of water, acidified with 45 ml of 20% sodium hydroxide and isolated by extraction with benzene; 0.90 g (70%) of oily Ig, Hydrogen maleate, m.p. 176-177 ° C (ethanol).
Příklad 8Example 8
N-Methy1-1-(2-(fenylaulfinyl)fenyl)-2-propylamin (Ih)N-Methyl-1- (2- (phenylaulfinyl) phenyl) -2-propylamine (Ih)
Podobnou oxidací 1,29 g aminu Ie v 13 ml kyseliny octové pomocí 0,8 g peroxidu vodíku se jako v předešlém příkladu získá 1,3 g (94 %) olejovitó base Ih, která ae převede na hydrogenmaleinat, t. t, 132 až 134 °C (ethanol).Similar oxidation of 1.29 g of amine Ie in 13 ml of acetic acid with 0.8 g of hydrogen peroxide gave, as in the previous example, 1.3 g (94%) of an oily base Ih which was converted to hydrogen maleate, m.p. 134 ° C (ethanol).
Příklad 9Example 9
N,N-Dimethy1-1-(2-(fenylaulfinyl)feny1)-2-propylamin (li)N, N-Dimethyl-1- (2- (phenylaulfinyl) phenyl) -2-propylamine (li)
Jako v předešlých příkladech ae oxiduje 1,4 g aminu If ve 14 ml kyaeliny octové pomocí 0,7 g 30% peroxidu vodíku. Získá se 1,4 g (97 %) olejovitého aminu li, který se převede na hydrogenmaleinat, t, t, 108'až 111 °C (ethanol-ether).As in the previous examples, ae is oxidized by 1.4 g of amine If in 14 ml of acetic acid with 0.7 g of 30% hydrogen peroxide. 1.4 g (97%) of an oily amine 11 are obtained, which is converted to the hydrogen maleate, m.p. 108-101 ° C (ethanol-ether).
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS201489A CS273750B1 (en) | 1989-03-31 | 1989-03-31 | 2-(phenylthio) phenylalkylamines, their s-oxides and salts with dicarboxylic acids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS201489A CS273750B1 (en) | 1989-03-31 | 1989-03-31 | 2-(phenylthio) phenylalkylamines, their s-oxides and salts with dicarboxylic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS201489A1 CS201489A1 (en) | 1990-08-14 |
| CS273750B1 true CS273750B1 (en) | 1991-04-11 |
Family
ID=5356015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS201489A CS273750B1 (en) | 1989-03-31 | 1989-03-31 | 2-(phenylthio) phenylalkylamines, their s-oxides and salts with dicarboxylic acids |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS273750B1 (en) |
-
1989
- 1989-03-31 CS CS201489A patent/CS273750B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS201489A1 (en) | 1990-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jones | Studies on imidazole compounds. I. A synthesis of imidazoles with functional groups in the 2-position | |
| SU1597096A3 (en) | Method of producing derivatives of diphenylpropyl amine or their pharmaceutically acceptable salts | |
| NL8702857A (en) | PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES, METHODS AND INTERMEDIATES FOR THE PREPARATION THEREOF, PREPARATIONS CONTAINING THESE DERIVATIVES, AND THE USE OF THESE DERIVATIVES FOR MEDICINE PURPOSES. | |
| IE43598B1 (en) | Erythromycin derivatives | |
| LU86435A1 (en) | NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| US4248884A (en) | 2-Pyrrolidine methanol derivatives utilizable as medicaments | |
| SU719498A3 (en) | Method of preparing 1-nitro-9-alkylaminoalkylaminoacridines or their salts | |
| Nagasawa et al. | New method for nitrosation of proline and related sec-. alpha.-amino acids to N-nitrosamino acids with possible oncogenic activity | |
| US4008232A (en) | 3-Amino-5,6-diaryl-1,2,4-triazines | |
| CS273750B1 (en) | 2-(phenylthio) phenylalkylamines, their s-oxides and salts with dicarboxylic acids | |
| SU1169538A3 (en) | Method of obtaining tricyclic compounds | |
| DE2605377A1 (en) | 0-AMINOOXIME, THE METHOD OF MANUFACTURING IT AND THE MEDICINAL PRODUCTS CONTAINING IT | |
| EP0079810B1 (en) | Derivatives of 4-phenyl-quinazoline active on the central nervous system | |
| DE2806909A1 (en) | METHOD FOR MANUFACTURING MEFLOQUIN | |
| FR2470770A1 (en) | NOVEL B-IMIDAZOLYLETHYL ETHERS OF QUINOLINE-2 OR 4-METHANOLS, PARTICULARLY USEFUL AS ANTIMICROBIALS, AND PROCESS FOR THE PREPARATION THEREOF | |
| Jacob III et al. | Sulfur analogues of psychotomimetic agents. Monothio analogs of mescaline and isomescaline | |
| FR2465733A1 (en) | NOVEL IMIDAZOLYLETHOXYMETHYLIC DERIVATIVES OF 1,3-DIOXOLOQUINOLINES USEFUL AS ANTIBACTERIAL AND ANTIFUNGAL DRUGS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS AND PHARMACEUTICAL FORMS CONTAINING THEM | |
| US4259257A (en) | 1-Phenyl-2-amino-1,3-propanediol-N-aryloxyalkyl derivatives | |
| EP0064006A1 (en) | Substituted 2,4-dialkoxybenzenesulfonyl chlorides | |
| FI56672C (en) | NYTT FOERFARANDE FOER FRAMSTAELLNING AV 2-AMINO-BENZAMINER | |
| CA1296337C (en) | Substituted 8-(phenylthio)-tetrahydroquinolines useful in the treatment of allergy | |
| Kawase et al. | Synthesis and biological evaluation of 4-fluoro-, 7-fluoro-, and 4, 7-difluoro-5, 6-dihydroxytryptamines | |
| SU1042614A3 (en) | Process for preparing 2-benzyl-3-(3-dimethylamino-propylthio)-2h-indasole | |
| DE2712045A1 (en) | DIBENZOTHIOPHENE DERIVATIVES | |
| FI59586C (en) | FRAMEWORK FOR THE PHARMACOLOGICAL PROPERTIES OF VARIABLE BENS-1,2-ISOXAZOLFOERENINGAR |